Advertisement

Topics

Companies Related to "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" [Most Relevant Company Matches] - Page: 20 RSS

23:21 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" found in our extensive corporate database of over 50,000 company records.

Showing "Development Algorithm Prediction Onset Hemodynamic Instability Humans" Companies 476–500 of 6,000+

Possibly Relevant

Neoparin, Inc.

Neoparin is committed to provide highest quality products and service for your present needs. We also recognize that the development of new products is necessary for continued success. We devote a large portion of our efforts to continuing development of innovative heparinoids. We welcome any suggestions, and will always strive to your needs.


KeyNeurotek AG

KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment of acute and chronic neurodegenerative disorders of the Central Nervous System (e.g. stroke and Alzheimer disease), the company merges superior expertise in neurobiology, preclinical and clinical drug development, medicinal chemistry and in sil...

Korea Health Industry Development Institute(KHIDI)

The Korea Health Industry Development Institute(KHIDI) is funded by the government and was established to support the Korean health industry. This industry will form an essential part of 21st century's knowledge based economy and will be of the greatest importance to the people's health.Advanced countries are aware of the importance and its leading role in the world's economy. Consequently they ha...


Watson Pharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a San Mateo, California-based specialty biopharmaceutical developer focused on clinically and commercially differentiated protein therapeutics. Itero leverages strategic collaborations to provide capital efficient process and manufacturing development as well as global clinical development and commercialization. The company's management team consists of accomplish...

Enzon Pharmaceuticals

We are a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening diseases. Our specialized sales force markets ABELCET®, ONCASPAR®, ADAGEN®, and DEPOCYT® in North America. In addition, we also receive royalties on sales of PEG-INTRON®, marketed by Schering-Plough Corporation, and MACUGEN®, marketed ...

CLARIGEN INC

Clarigen, Inc., headquartered in Carlsbad, California, is a biotechnology company, a leader in bio-contamination removal. The company is applying a broad and integrated scientific approach to the development of innovative products for preventing and treating medical conditions caused by infectious agents and their products. Clarigen is strongly committed to research as an essential component of it...

Bio Balance, Inc.

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals. Bio Balance is devoted to a biophysical description of the initial receptor response. This should lead to improved pharmaceuticals and be an attr...

Corus Pharma Inc

Corus Pharma seeks to develop drugs to treat unmet needs in the infectious diseases and respiratory areas. The company's core competencies reside in the identification of drug candidates, rapid clinical development and FDA approval of its products. Target development candidates will be identified through a combination of internal ideas, academic research and a search of projects in other organizat...

Cell Essentials, Inc.

Cell Essentials provides contract cell biology-based services facilitating the creation of reagents for use in diagnostics and drug discovery as well as basic research. Major services include the development of custom hybridomas and production of monoclonal antibodies, large scale cell culture, stable cell line development, cell-based assay development, cell banking, and peptide synthesis. Adenovi...

CEL-SCI

CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The Company’s core capabilities include drug discovery, research, development and manufacturing of complex biological substances.

PrimeSyn Lab Inc.

PrimeSyn Lab, Inc. (PSL) is a recognized leader in the area of Custom Oligos /GMP Oligos and specializes in ULTRA PURE Oligonucleotides and Analyte Specific Reagent (ASR) primers and probes for: Cloning, Mutagenesis, Fluorescent Sequencing, Microarrays, Diagnostics and Therapeutics. PSL also provides contract analytical lab services including method development, assay development and consultancy. ...

Panlabs Incorporated

Drug discovery servicesAssay development and optimization Pharmacological profiling Process improvement servicesFermentation yield improvement (classical and molecular) Fermentation process development Pathway engineering Gene expression Bio-transformation Antibiotic technologies

ZymeTx Incorporated

ZymeTx Incorporated is a development stage biotechnology company engaged in the discovery, development and commercialization of unique products for the diagnosis and treatment of viruses. The scientific foundation for our businessis based upon the role of enzymes in the process of viral infection.

Economic Development Council of Seattle & King County

For 45 years, the EDC has provided confidential, free-of-charge consulting services to individual business clients, entrepreneurs, site selection decision makers and consultants working with companies seeking to do business in King County and its 39 cities. The EDC provides a unique set of services, tailored to the specific needs of our clients and focused...

BioSeek, Inc

BioSeek is committed to improving the success rate of pharmaceutical development by integrating human biology from the early stages of drug discovery through preclinical development. Our BioMAP® systems incorporate predictive human cell-based disease models that generate uniquely informative biological activity signatures for each potential drug, yielding actionable data to drive the selection a...

Prairie Plant Systems Inc.

Prairie Plant Systems was established in 1988 as a privately held plant biotechnology company with a focus on research and development. Initial research efforts concentrated on the development of micropropagation protocols for the saskatoon berry tree, a hardy fruit-bearing tree native to Saskatchewan, Canada. The research focused on enhancing both micropropagation and in vivo rooting techniques t...

PRN Pharmaceutical Research Network

We provide consulting services to pharmaceutical research + development and marketing departments. We focus on clinical trial planning, feasibility of development plans, study design, protocol development, manuscript creation and management, lectures and physician education plans.We provide non-proprietary competitive intelligence and ophthalmic product feasibility assessments to financial and ph...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceuticals) technology. LEAP combines the power of biological selection with the advantages of medicinal chemistry in a unique molecular evolution process. PRAECIS employed LEAP in the development of PLENA...

RegeneRx Pharmaceuticals, Inc.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three strategic licensing agreements in China, Pan Asia (Korea, Japan, and Australia, among oth...

Transave, Inc.

Transave, Inc., is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of chronic lung diseases. The company's major focus is on developing antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. The Transave team is dedicated to leveraging its develo...

Knopp Neurosciences Inc.

Knopp Neurosciences, based in Pittsburgh, PA, USA, is a drug discovery and development company focused on delivering breakthrough treatments for neurological disorders through innovation, experience, and partnership. The company’s lead product candidate is KNS-760704, an orally bioavailable small molecule in development for the treatment of ALS. Knopp...

SuperGen, Inc.

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com...

DIATOS S.A

Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and dru...

Inhibitex, Inc.

Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing innovative products to prevent and treat serious infectious diseases. The Company’s pipeline includes FV-100, which is in Phase II clinical development for the treatment of shingles; INX-189, a nucleotide polymerase inhibitor in Phase I clinical...

Trillium Medical Ventures, LLC

Trillium Medical Ventures, LLC, a bio science technology assessment firm founded in 1998, evaluates life science intellectual property and technology with the objective of identifying unique and valuable life science investment and product development opportunities. Trillium has extensive experience in the identification and analysis of biopharmaceutical and pharmaceutical intellectual-property li...


More From BioPortfolio on "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks